Brandy Bennett

Company: Regeneron

Job title: Head of Obesity Center Strategy & Business Operations

Seminars:

Panel Discussion: Considering the Future of Obesity Therapeutics: Beyond Appetite Suppression for More Varied Treatment Options 3:30 pm

Discussing the limitations of current therapies that primarily focus on appetite suppression Exploring new targets and delving into emerging areas of research, such as targeting metabolic pathways, gut microbiota modulation, and precision medicine approaches Exploring the potential of combining different therapies and modalities to achieve more comprehensive and sustainable weight lossRead more

day: Day Two

Muscle-Targeted Therapeutics That Can Be Combined with Obesity Drugs to Improve the Quality of Weight Management 2:40 pm

Addressing the concern of muscle loss, as a side effect of GLP-1 medications, through the development of muscle preservation and stimulation approaches Exploring the synergistic potential of combining these muscle stimulants with existing obesity therapies to improve weight loss outcomes Optimizing the development of safe and effective muscle stimulants by focusing on specific targets and…Read more

day: Day One